Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Early communication regarding cancer link in children
The FDA has issued an early communication today regarding a possible link between the use of medicines known as tumour necrosis factor (TNF) blockers (such as { drug_name }) and the development of lymphoma and other cancers in children and young adults. The FDA is currently investigating this issue and will continue to report as new information emerges. Today's announcement follows approximately 30 reports of cancer in children and young adults treated with TNF blockers for Juvenile Idiopathic Arthritis (JIA), Crohn's disease or other diseases. While cancers are known to occur in children and young adults, these reports in children and young adults receiving TNF blockers are of concern and have prompted the FDA's further investigation.
Learn More

Early communication regarding cancer link in children
The FDA has issued an early communication today regarding a possible link between the use of medicines known as tumour necrosis factor (TNF) blockers (such as { drug_name }) and the development of lymphoma and other cancers in children and young adults. The FDA is currently investigating this issue and will continue to report as new information emerges. Today's announcement follows approximately 30 reports of cancer in children and young adults treated with TNF blockers for Juvenile Idiopathic Arthritis (JIA), Crohn's disease or other diseases. While cancers are known to occur in children and young adults, these reports in children and young adults receiving TNF blockers are of concern and have prompted the FDA's further investigation.
Learn More